Atomi Financial Group, Inc. Bristol Myers Squibb CO Transaction History
Atomi Financial Group, Inc.
- $3.09 Trillion
- Q3 2025
A detailed history of Atomi Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 11,561 shares of BMY stock, worth $541,170. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,561
Previous 7,692
50.3%
Holding current value
$541,170
Previous $356 Million
46.44%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,692Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...